XML 267 R39.htm IDEA: XBRL DOCUMENT v3.24.2.u1
BASIS OF FINANCIAL STATEMENT PREPARATION (Details)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
USD ($)
Jun. 30, 2023
USD ($)
Jun. 30, 2024
USD ($)
country
segment
Jun. 30, 2023
USD ($)
Dec. 31, 2023
Concentration Risk [Line Items]          
Number of reportable segments | segment     1    
Number of operating segments | segment     1    
Number of countries with primary office locations | country     5    
Selling, general and administrative expenses, exclusive of depreciation and amortization $ 156.2 $ 97.8 $ 276.3 $ 214.6  
Decrease of direct costs $ (525.3) (568.7) $ (1,079.5) (1,110.2)  
Interest expense       0.1  
Reclassifications          
Concentration Risk [Line Items]          
Selling, general and administrative expenses, exclusive of depreciation and amortization   33.1   78.3  
Decrease of direct costs   $ 33.1   $ 78.3  
Customer one | Accounts receivable and unbilled services | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage     15.40%    
Customer one | Revenue | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage 13.20% 10.20% 13.60% 10.10%  
Customer two | Revenue | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage     11.30%    
Pharmaceutical company one | Accounts receivable and unbilled services | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage         17.00%
Pharmaceutical company two | Accounts receivable and unbilled services | Customer concentration risk          
Concentration Risk [Line Items]          
Concentration risk, percentage         11.20%